Prostate cancer: Radiation therapy effective in patients with no further treatment options
Reports of new cancer treatments often raise high hopes and expectations, particularly, of course, among…
Monthly Archives: November, 2019
Phase II trial shows neurocognitive function decline but stable quality of life in first year after temozolomide-based chemoradiotherapy
A secondary analysis of the phase II clinical trial NRG-RTOG 0424, which initially reported a 73.1%…
Breakthrough in understanding neuroblastoma – a common childhood cancer
Scientists studying one of the most common forms of childhood cancer have made an important…
Cellular origins of paediatric brain tumours identified
A research team led by Dr Claudia Kleinman, an investigator at the Lady Davis Institute…
Tackling taboos: Can we agree on how to talk about end-of-life with young people?
A death illiterate society We, as a society, are not particularly good at dealing with…
Some patients with suspected cancer fail to attend referral appointments – we found out why
Peter Knapp, University of York If a patient has signs or symptoms of cancer, a…
‘Magic bullet’ takes aim at pancreatic cancer
Every day, more than 1200 people worldwide are told they have pancreatic cancer. Within 12…
Encouraging normal liver cells to fight cancer
A study conducted at the VIB-KU Leuven Center for Cancer Biology discovered that healthy liver…
Biennial mammography screening yields more advanced-stage cancers
Cancers found in patients undergoing annual mammography screening are smaller and less advanced than those…
New antitumoural drug release strategy created for breast cancer treatment
The local release of antitumoural drugs through bacterial proteins in the treatment of breast cancer…